WO2023106123A1 - Cosmetic - Google Patents

Cosmetic Download PDF

Info

Publication number
WO2023106123A1
WO2023106123A1 PCT/JP2022/043475 JP2022043475W WO2023106123A1 WO 2023106123 A1 WO2023106123 A1 WO 2023106123A1 JP 2022043475 W JP2022043475 W JP 2022043475W WO 2023106123 A1 WO2023106123 A1 WO 2023106123A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic
component
mass
acid
polyoxyethylene
Prior art date
Application number
PCT/JP2022/043475
Other languages
French (fr)
Japanese (ja)
Inventor
佳奈子 小門
裕介 奥山
育浩 鈴木
Original Assignee
株式会社 資生堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社 資生堂 filed Critical 株式会社 資生堂
Publication of WO2023106123A1 publication Critical patent/WO2023106123A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/34Ethylene-urea

Definitions

  • the present invention relates to a cosmetic comprising a cyclic carboxamide derivative having a specific structure or a salt thereof and fine cellulose fibers.
  • cellulose nanofibers which are finer cellulose fibers
  • a viscous aqueous composition containing a combination of cellulose fibers having a specific fiber diameter and structure and a thickening accelerator has been proposed, and it is disclosed that a small amount increases the thickening effect (Patent Document 1).
  • Patent Document 1 a viscous aqueous composition containing a combination of cellulose fibers having a specific fiber diameter and structure and a thickening accelerator has been proposed, and it is disclosed that a small amount increases the thickening effect.
  • Patent Document 1 With regard to such cosmetics, users are demanding that they have a better feeling during use, and there is room for further improvement in the feeling during use.
  • cyclic carboxamide derivatives tend to be sticky when used in cosmetics.
  • the present inventors have surprisingly found that using a cosmetic containing a combination of fine cellulose fibers and a specific cyclic carboxamide derivative can achieve excellent usability.
  • the present invention is based on these findings.
  • a cyclic carboxamide derivative represented by formula (1) or a salt thereof (In the formula, R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, X is —CH 2 — or —N(R 2 )—, wherein R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, and n is an integer from 1 to 3),
  • a cosmetic comprising (B) fine cellulose fibers and (C) water.
  • R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms
  • the component (B) has a maximum fiber diameter of 1000 nm or less.
  • the present invention it is possible to provide cosmetics with excellent usability.
  • freshness and fit are obtained during application, and the skin is moisturized after application, and stickiness is suppressed.
  • the present invention relates to a cosmetic comprising (A) a cyclic carboxamide derivative having a specific structure or a salt thereof, (B) fine cellulose fibers, and (C) water.
  • the cosmetic according to the present invention is a cyclic carboxamide derivative represented by formula (1) or a salt thereof (hereinafter sometimes referred to as component (A). The same applies to other components). There is.).
  • component (A) Cyclic carboxamide derivative or salt thereof
  • R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom
  • X is —CH 2 — or —N(R 2 )—
  • R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom
  • n is an integer of 1-3.
  • the above hydrocarbon group is not particularly limited, and may be, for example, an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, a cycloalkylalkyl group, a haloalkyl group, an alkoxyalkyl group, or an alkoxycarbonylalkyl group, preferably is an alkyl group.
  • R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms
  • X is —CH 2 — or —NH—
  • n is 1.
  • Specific examples of the cyclic carboxamide derivative represented by formula (1) include the following.
  • Component (A) is most preferably 1-(2-hydroxyethyl)-2-imidazolidinone.
  • the (A) component may be a salt of the cyclic carboxamide derivative represented by formula (1).
  • the type of salt is not particularly limited as long as it is a pharmacologically acceptable salt, and may be an inorganic salt or an organic salt.
  • inorganic salts include hydrochlorides, sulfates, phosphates, hydrobromides, sodium salts, potassium salts, magnesium salts, calcium salts, magnesium salts, ammonium salts and the like.
  • organic salts include acetates, lactates, maleates, fumarates, tartrates, methanesulfonates, p-toluenesulfonates, triethanolamine salts, amino acid salts and the like.
  • component (A) component can be blended one or two or more.
  • the amount of component (A) is preferably 0.05 to 7% by mass, more preferably 0.1 to 6% by mass, and still more preferably 1 to 6% by mass, relative to the total amount of the cosmetic. is.
  • component (B) Fine Cellulose Fibers
  • component (B) means nanofibers (microfibrils) made of plant-derived cellulose.
  • Component (B) is more preferably composed of microfibrils substantially dispersed one by one (also called cellulose single nanofibers: CSNF). Cellulose single nanofibers have a high thickening effect on water.
  • component (B) Component preferably contains crystalline cellulose. More preferably, the cellulose constituting component (B) has a type I crystal structure.
  • the component (B) is fibers obtained by subjecting a naturally-derived solid cellulose raw material having a type I crystal structure to surface oxidation and refining. In the process of biosynthesis of natural cellulose, nanofibers called microfibrils are first formed almost without exception, and these bundles are bundled to form a higher-order solid structure. In order to weaken the intersurface hydrogen bonds that drive the strong cohesive forces between microfibrils, some of the hydroxyl groups have been oxidized and converted to aldehyde and carboxyl groups.
  • component (B) is modified by selectively oxidizing the hydroxyl group at the C6 position of the glucose unit in the cellulose molecule into an aldehyde group and a carboxyl group.
  • the amount of carboxyl groups is preferably 0.6 to 2.2 mmol/g, more preferably 0.6 to 2.0 mmol/g from the viewpoint of shape retention performance and dispersion stability.
  • the amount of aldehyde groups is preferably 0.03-0.3 mmol/g, more preferably 0.10-0.25 mmol/g.
  • the amount of carboxyl groups and the amount of aldehyde groups contained in the fine cellulose fibers can be measured by potentiometric titration of water in which the fine cellulose fibers are dispersed.
  • the amount of carboxyl groups and the amount of aldehyde groups in the fine cellulose fibers can be adjusted by controlling the amount of co-oxidizing agent added and the reaction time used in the step of oxidizing the cellulose fibers. Further, introduction of an aldehyde group or a carboxyl group into the fine cellulose fibers can be confirmed by total reflection infrared spectroscopy (ATR) analysis.
  • ATR total reflection infrared spectroscopy
  • the maximum fiber diameter of component (B) is preferably 1000 nm or less, more preferably 1000 nm or less and a number average fiber diameter of 2 to 100 nm, and from the viewpoint of dispersion stability, the maximum fiber diameter is 500 nm. It is more preferable that the number average fiber diameter is 3 to 80 nm.
  • the number average fiber diameter and maximum fiber diameter of fine cellulose fibers can be measured, for example, as follows. Water is added to the cellulose fibers to adjust the solid content of cellulose to 1% by mass.
  • Japanese Patent No. 5243371 The method disclosed in Japanese Patent No. 5243371 can be adopted as the above-described specific method for measuring fine cellulose fibers.
  • component (B) for example, a product commercially available from Daiichi Kogyo Seiyaku Co., Ltd. under the trade name of "Rheocrysta” can be used.
  • “Rheocrysta C-2SP” (trade name) is a product containing 2% by mass of fine cellulose fibers, 1% by mass of phenoxyethanol in 97% by mass of water.
  • the blending amount of component (B) is preferably 0.005 to 1% by mass, more preferably 0.005 to 0.3% by mass, and still more preferably 0.015, relative to the total amount of the cosmetic. 0.15% by mass, and more preferably 0.015 to 0.08% by mass.
  • the blending amount of component (A) with respect to the blending amount of component (B) ((A)/(B)) is preferably 1-300, more preferably 50-280, in mass ratio.
  • the cosmetic according to the present invention comprises (C) water.
  • water water used in cosmetics, quasi-drugs, etc. can be used, and for example, purified water, ion-exchanged water, tap water, etc. can be used.
  • the blending amount of water is preferably 40 to 95% by mass, more preferably 50 to 90% by mass, based on the total amount of the cosmetic composition according to the present invention.
  • Succinoglycans are a class of microbially derived polysaccharides derived from sugar units derived from galactose and glucose, plus succinic and pyruvic acids and optionally acetic acid, or salts of these acids. It contains units. More specifically, succinoglycans are water-soluble macromolecules containing approximately 7:1:1:1 glucose units: galactose units: succinate units: pyruvate units.
  • the blending amount of component (D) is preferably 0.005 to 1% by mass, more preferably 0.01 to 0.5% by mass, and still more preferably 0.01%, based on the total amount of the cosmetic. ⁇ 0.1% by mass.
  • the blending amount of component (A) relative to the blending amount of component (D) ((A)/(D)) is preferably 1 to 300, more preferably 50 to 200, in mass ratio.
  • the cosmetic according to the present invention may further contain (E) polyethylene glycol (PEG).
  • Component (E) preferably has a weight average molecular weight of 150 to 23,000, more preferably 150 to 3,000.
  • Component (E) includes, for example, PEG-6, PEG-20, PEG-32, PEG-75, PEG-400 and the like.
  • component (E) component can be blended one or two or more.
  • the blending amount of component (E) is preferably 0.1 to 5% by mass, more preferably 0.3 to 3% by mass, and still more preferably 0.7 to 2%, based on the total amount of the cosmetic. % by mass.
  • the cosmetics according to the present invention can contain optional ingredients that are usually used in cosmetics and pharmaceuticals.
  • optional ingredients include moisturizers, lower alcohols, thickeners, surfactants, sequestering agents, neutralizers, pH adjusters, antioxidants, preservatives, drugs, and the like, and the effects of the present invention. 1 or 2 or more can be blended as long as the
  • moisturizing agents examples include propylene glycol, dipropylene glycol (DPG), glycerin, 1,3-butylene glycol (BG), erythritol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronin acid, Atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salts, dl-pyrrolidone carboxylate, short-chain soluble collagen, rose rose extract, yarrow extract, melilot extract and the like.
  • DPG dipropylene glycol
  • BG 1,3-butylene glycol
  • BG 1,3-butylene glycol
  • sorbitol maltitol
  • maltitol maltitol
  • chondroitin sulfate hyaluronic acid
  • mucoitin sulfate caronin
  • lower alcohols examples include ethanol, 1-propanol, 2-propanol, isobutyl alcohol, t-butyl alcohol and the like.
  • Thickeners include, for example, gum arabic, carrageenan, karaya gum, tragacanth gum, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium araginate, PVA, PVM, PVP, sodium polyacrylate, Carboxyvinyl polymer (carbomer), (dimethylacrylamide/acryloyldimethyltaurate Na) crosspolymer, (acryloyldimethyltaurate ammonium/VP) copolymer, (acryloyldimethyltaurate ammonium methacrylate beheneth-25) crosspolymer, (acrylate Na/ Acryloyldimethyltaurate Na) copolymer, locust bean gum, guar gum, tamarind gum, xanthan gum, magnesium aluminum silicate, bentonite, hectorite, A1Mg silicate (Vegum), laponite, silicic anhydride and the like.
  • Lipophilic nonionic surfactants include, for example, lipophilic nonionic surfactants such as sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostea sorbitan fatty acid esters such as sorbitan sesquioleate, diglycerol sorbitan penta-2-ethylhexylate, glycerin such as glyceryl monostearate, ⁇ , ⁇ '-oleic acid pyroglutamic acid glyceryl, glyceryl monostearate malate or Polyglycerin esters, propylene glycol fatty acid esters such as propylene glycol monostearate, hydrogenated castor oil derivatives, glycerin alkyl ethers and the like can be mentioned.
  • lipophilic nonionic surfactants such as sorbitan monooleate, sorbitan monoisostearate, sorb
  • hydrophilic nonionic surfactants include polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene sorbitan monooleate and polyoxyethylene sorbitan monostearate; polyoxyethylene sorbit monolaurate, polyoxyethylene sorbit Polyoxyethylene sorbitol fatty acid esters such as monooleate and polyoxyethylene sorbitol monostearate; Polyoxyethylene fatty acid esters such as oxyethylene glycerin fatty acid ester, polyoxyethylene monooleate, polyoxyethylene distearate; polyoxyethylene lauryl ether, polyoxyethylene oleyl ether, polyoxyethylene stearyl ether, polyoxyethylene -polyoxyethylene alkyl ethers such as 2-octyldodecyl ether and polyoxyethylene cholestanol ether; polyoxyethylene alkyl ethers such as polyoxyethylene octylphenyl ether, polyoxyethylene nonylphenyl ether and polyoxyethylene din
  • polyoxyethylene propylene glycol fatty acid esters polyoxyethylene alkylamines, polyoxyethylene fatty acid amides, sucrose fatty acid esters, polyoxyethylene nonylphenyl formaldehyde condensates, alkylethoxydimethylamine oxides, trioleyl phosphate, etc. be done.
  • anionic surfactants include fatty acid soaps such as sodium laurate and sodium palmitate; higher alkyl sulfate salts such as sodium lauryl sulfate and potassium lauryl sulfate; Alkyl ether sulfate ester salts such as sodium lauryl sulfate; N-acylsarcosic acid such as sodium lauroyl sarcosinate, sodium N-myristoyl-N-methyltaurate, sodium N-stearoyl-N-methyltaurate, sodium cocoate methyl tauride, Higher fatty acid amide sulfonates such as sodium lauryl methyl tauride; Phosphate ester salts such as sodium polyoxyethylene oleyl ether phosphate and sodium polyoxyethylene stearyl ether phosphate; sulfosuccinates such as sodium ethanolamide polyoxyethylene sulfosuccinate and sodium lauryl polypropylene glycol sulfosuccinate;
  • cationic surfactants include alkyltrimethylammonium salts such as stearyltrimethylammonium chloride and lauryltrimethylammonium chloride; dialkyldimethylammonium salts such as distearyldimethylammonium chloride; ,-methylenepiperidinium), alkylpyridinium salts such as cetylpyridinium chloride, alkylquaternary ammonium salts, alkyldimethylbenzylammonium salts, alkylisoquinolinium salts, dialkylmorphonium salts, polyoxyethylenealkylamines, Alkylamine salts, polyamine fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride, benzethonium chloride, cationic polymers, ⁇ -NN-dimethyl-N-ethylammonioethyl chloride vinylpyrrolidone chloride copolymers, etc. be done.
  • Amphoteric surfactants include, for example, 2-undecyl-N,N,N,-(hydroxyethylcarboxymethyl)-2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy 2 imidazoline-based amphoteric surfactants such as sodium salts; betaine-based amphoteric surfactants such as 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetate betaine, alkylbetaine, amidobetaine, sulfobetaine, etc. agents and the like.
  • sequestering agents include 1-hydroxyethane-1,1-diphosphonic acid, tetrasodium 1-hydroxyethane-1,1-diphosphonic acid, disodium edetate (EDTA-2Na), and trisodium edetate.
  • EDTA-2Na disodium edetate
  • trisodium edetate tetrasodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, succinic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate, and the like.
  • neutralizing agents examples include 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, potassium hydroxide, sodium hydroxide, triethanolamine, sodium carbonate, and the like. is mentioned.
  • pH adjusters include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
  • antioxidants include dibutylhydroxytoluene, butylhydroxyanisole, sodium pyrosulfite, and gallic acid esters.
  • antiseptics include paraoxybenzoic acid esters such as methylparaben, ethylparaben, and butylparaben, benzoic acid, salicylic acid, sorbic acid, parachlorometacresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, and trichlorocarbanilide. , a photosensitive element, phenoxyethanol, and the like.
  • drugs include ascorbic acid (vitamin C), tranexamic acid, kojic acid, ellagic acid, arbutin, alkoxysalicylic acid, glycyrrhizic acid, tocopherol, retinol, and salts or derivatives thereof (e.g., sodium L-ascorbate, L -ascorbic acid ester magnesium salt, L-ascorbic acid glucoside, 2-O-ethyl-L-ascorbic acid, 3-O-ethyl-L-ascorbic acid, 4-methoxysalicylic acid sodium salt, 4-methoxysalicylic acid potassium salt, glycyrrhizin dipotassium acid, stearyl glycyrrhizinate, tocopherol acetate, retinol acetate, retinol palmitate, etc.), nicotinic acid and its derivatives (e.g.
  • nicotinamide caffeine, tannins, verapamil and its derivatives, licorice extract, glabridin, fire thorns fruit hot water extract, various crude drugs, hydrolyzed silk, hydrolyzed conchiolin, tea extract, tormentilla root extract, Angelica keiskei leaf/stem extract, aloe vera leaf extract, cherry leaf extract, angelica root extract, shiikuwasha pericarp extract, iris root extract , Soarthorn/Hijirimen/Mitsui kelp/Usuva green laver/Wakame extract, Cattail extract, Toad leaf/stem extract, Camellia seed extract, Honey kelp/Wakame extract, Mishima radish root extract, Dutch mustard leaf/stem extract, Cassia bark extract, Rosemary Leaf oil, lavender oil, glutamic acid, trimethylglycine, chlorphenesin, menthoxypropanediol and the like.
  • UV absorbers powder ingredients, fragrances, etc. can be added as appropriate.
  • the dosage form of the cosmetic according to the present invention is not particularly limited and includes, for example, a solution system, a solubilization system, an emulsification system, a water-2-oil two-layer system, and a water-oil-powder three-layer system.
  • Cosmetics according to the present invention include, for example, skin care cosmetics (e.g. lotions, milky lotions, creams, serums, packs, etc.), makeup cosmetics (e.g., foundations, makeup bases, etc.), skin cleansers (e.g., facial cleansers). cosmetics, makeup removers, etc.), sunscreen cosmetics, ointments, and the like.
  • the cosmetic of the present invention can be produced according to a conventional method.
  • the method of emulsification is not particularly limited.
  • Examples 1 to 13 and Comparative Examples 1 and 2 Cosmetics of Examples 1 to 13 and Comparative Examples 1 and 2 were prepared with the formulations shown in Tables 1 and 2.
  • crystalline cellulose (cellulose nanofiber) * 1 is fine fibrous cellulose fine cellulose (“Rheocrysta C-2SP” (trade name), manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) having a maximum fiber diameter of 1000 nm or less.
  • “Rheocrysta C-2SP” is a product containing 2% by mass of fine fibrous cellulose, 1% by mass of phenoxyethanol (preservative) in 97% by mass of water, and is described in the specification and tables. % by mass indicates only fine fibrous cellulose, and does not include water and preservatives contained in the product.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

[Problem] To provide a cosmetic that gives a good feel when used. [Solution] Provided is a cosmetic comprising (A) a cyclic carboxamide derivative having a specific structure, or a salt thereof, (B) cellulose microfibers, and (C) water.

Description

化粧料cosmetics
 本発明は、特定の構造を有する環状カルボキサミド誘導体またはその塩、および微細セルロース繊維を含んでなる化粧料に関する。 The present invention relates to a cosmetic comprising a cyclic carboxamide derivative having a specific structure or a salt thereof and fine cellulose fibers.
 セルロース繊維を微細化したセルロースナノファイバーが、増粘性や分散安定性を付与する目的等で、化粧料に配合されることが知られている。例えば、特定の繊維径や構造を有するセルロース繊維と増粘促進剤との組み合わせを含む粘性水系組成物が提案されており、少量で増粘効果を高めることが開示されている(特許文献1)。このような化粧料について、使用者はより優れた使用感を有することを求めており、さらなる使用感の改善の余地があった。 It is known that cellulose nanofibers, which are finer cellulose fibers, are added to cosmetics for the purpose of imparting thickening properties and dispersion stability. For example, a viscous aqueous composition containing a combination of cellulose fibers having a specific fiber diameter and structure and a thickening accelerator has been proposed, and it is disclosed that a small amount increases the thickening effect (Patent Document 1). . With regard to such cosmetics, users are demanding that they have a better feeling during use, and there is room for further improvement in the feeling during use.
 一方、環状カルボキサミド誘導体は、抗しわ効果や色素沈着抑制効果があることが知られており、化粧料等に配合することが提案されている(特許文献2)。 On the other hand, cyclic carboxamide derivatives are known to have anti-wrinkle and anti-pigmentation effects, and have been proposed to be added to cosmetics (Patent Document 2).
特開2012-126788号公報JP 2012-126788 A 国際公開2011/040496International publication 2011/040496
 本発明者らの検討によると、環状カルボキサミド誘導体を化粧料に用いる場合に、べたつきを生じやすい傾向にあることがわかってきた。本発明者らは、驚くべきことに、微細セルロース繊維と、特定の環状カルボキサミド誘導体との組み合わせを含む化粧料を用いることで、優れた使用感を達成できることを見いだした。本発明はこれらの知見に基づくものである。 According to the studies of the present inventors, it has been found that cyclic carboxamide derivatives tend to be sticky when used in cosmetics. The present inventors have surprisingly found that using a cosmetic containing a combination of fine cellulose fibers and a specific cyclic carboxamide derivative can achieve excellent usability. The present invention is based on these findings.
 本発明によれば、以下の発明が提供される。
[1](A)式(1)で表される環状カルボキサミド誘導体またはその塩
Figure JPOXMLDOC01-appb-C000002
(式中、
 Rは、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、
 Xは、-CH-または-N(R)-であり、ここで、Rは、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、かつ
 nは、1~3の整数である)、
(B)微細セルロース繊維、および
(C)水
を含んでなる化粧料。
[2](A)成分の式(1)において、
 Rが、炭素数1~3のヒドロキシアルキル基であり、
 Xが、-CH-または-NH-であり、かつ
 nが、1である、[1]に記載の化粧料。
[3](A)成分が、1-(2-ヒドロキシエチル)-2-イミダゾリジノンである、[1]または[2]に記載の化粧料。
[4](A)成分の配合量が、化粧料の総量に対して、0.05~7質量%である、[1]~[3]のいずれかに記載の化粧料。
[5](B)成分の最大繊維径が1000nm以下である、[1]~[4]のいずれかに記載の化粧料。
[6](B)成分の配合量が、化粧料の総量に対して、0.005~1質量%である、[1]~[5]のいずれかに記載の化粧料。
[7](B)成分の配合量に対する(A)成分の配合量((A)/(B))が、質量比で、1~300である、[1]~[6]のいずれかに記載の化粧料。
[8](D)サクシノグリカンをさらに含んでなる、[1]~[7]のいずれかに記載の化粧料。
[9](D)成分の配合量が、化粧料の総量に対して、0.005~1質量%である、[8]に記載の化粧料。
[10](E)ポリエチレングリコールをさらに含んでなる、[1]~[9]のいずれかに記載の化粧料。
[11](E)成分の配合量が、化粧料の総量に対して、0.1~5質量%である、[10]に記載の化粧料。
According to the present invention, the following inventions are provided.
[1] (A) a cyclic carboxamide derivative represented by formula (1) or a salt thereof
Figure JPOXMLDOC01-appb-C000002
(In the formula,
R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom,
X is —CH 2 — or —N(R 2 )—, wherein R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, and n is an integer from 1 to 3),
A cosmetic comprising (B) fine cellulose fibers and (C) water.
[2] In the formula (1) of the component (A),
R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms,
The cosmetic according to [1], wherein X is —CH 2 — or —NH—, and n is 1.
[3] The cosmetic of [1] or [2], wherein component (A) is 1-(2-hydroxyethyl)-2-imidazolidinone.
[4] The cosmetic according to any one of [1] to [3], wherein the amount of component (A) is 0.05 to 7% by mass relative to the total amount of the cosmetic.
[5] The cosmetic according to any one of [1] to [4], wherein the component (B) has a maximum fiber diameter of 1000 nm or less.
[6] The cosmetic according to any one of [1] to [5], wherein the amount of component (B) is 0.005 to 1% by mass relative to the total amount of the cosmetic.
[7] Any one of [1] to [6], wherein the blending amount of component (A) relative to the blending amount of component (B) ((A)/(B)) is 1 to 300 by mass. Cosmetics as described.
[8] The cosmetic according to any one of [1] to [7], further comprising (D) succinoglycan.
[9] The cosmetic according to [8], wherein the amount of component (D) is 0.005 to 1% by mass relative to the total amount of the cosmetic.
[10] (E) The cosmetic according to any one of [1] to [9], further comprising polyethylene glycol.
[11] The cosmetic according to [10], wherein the amount of component (E) is 0.1 to 5% by mass relative to the total amount of the cosmetic.
 本発明によれば、使用感に優れた化粧料を提供することができる。特に、塗布中に、みずみずしさや、フィット感が得られ、かつ、塗布後に肌がしっとりし、べたつきも抑制される。 According to the present invention, it is possible to provide cosmetics with excellent usability. In particular, freshness and fit are obtained during application, and the skin is moisturized after application, and stickiness is suppressed.
発明の具体的説明Specific description of the invention
 本発明は、(A)特定の構造を有する環状カルボキサミド誘導体またはその塩、(B)微細セルロース繊維、および(C)水を含んでなる化粧料に関するものである。 The present invention relates to a cosmetic comprising (A) a cyclic carboxamide derivative having a specific structure or a salt thereof, (B) fine cellulose fibers, and (C) water.
(A)環状カルボキサミド誘導体またはその塩
 本発明による化粧料は、式(1)で表される環状カルボキサミド誘導体またはその塩(以下、(A)成分と称することがある。他の成分についても同様である。)を含んでなる。
Figure JPOXMLDOC01-appb-C000003
式中、
 Rは、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、
 Xは、-CH-または-N(R)-であり、ここで、Rは、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、かつ
 nは、1~3の整数である。
 上記の炭化水素基は、特に限定されず、例えば、アルキル基、シクロアルキル基、アルケニル基、アルキニル基、シクロアルキルアルキル基、ハロアルキル基、アルコキシアルキル基、アルコキシカルボニルアルキル基であってよく、好ましくはアルキル基である。
(A) Cyclic carboxamide derivative or salt thereof The cosmetic according to the present invention is a cyclic carboxamide derivative represented by formula (1) or a salt thereof (hereinafter sometimes referred to as component (A). The same applies to other components). There is.).
Figure JPOXMLDOC01-appb-C000003
During the ceremony,
R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom,
X is —CH 2 — or —N(R 2 )—, wherein R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, and n is an integer of 1-3.
The above hydrocarbon group is not particularly limited, and may be, for example, an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, a cycloalkylalkyl group, a haloalkyl group, an alkoxyalkyl group, or an alkoxycarbonylalkyl group, preferably is an alkyl group.
 好ましい形態において、(A)成分の式(1)において、
 Rが、炭素数1~3のヒドロキシアルキル基であり、
 Xが、-CH-または-NH-であり、かつ
 nが、1である。
 式(1)で表される環状カルボキサミド誘導体の具体例としては、例えば、以下が挙げられる。
Figure JPOXMLDOC01-appb-C000004
 (A)成分は、最も好ましくは、1-(2-ヒドロキシエチル)-2-イミダゾリジノンである。
In a preferred form, in the formula (1) of component (A),
R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms,
X is —CH 2 — or —NH—, and n is 1.
Specific examples of the cyclic carboxamide derivative represented by formula (1) include the following.
Figure JPOXMLDOC01-appb-C000004
Component (A) is most preferably 1-(2-hydroxyethyl)-2-imidazolidinone.
 (A)成分は、式(1)で表される環状カルボキサミド誘導体の塩であってもよい。塩の種類は、薬理学的に許容される塩であれば特に限定されず、無機塩であっても有機塩であってもよい。無機塩としては、例えば、塩酸塩、硫酸塩、リン酸塩、臭化水素酸塩、ナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等が挙げられる。有機塩としては、例えば、酢酸塩、乳酸塩、マレイン酸塩、フマル酸塩、酒石酸塩、メタンスルホン酸塩、p-トルエンスルホン酸塩、トリエタノールアミン塩、アミノ酸塩等が挙げられる。 The (A) component may be a salt of the cyclic carboxamide derivative represented by formula (1). The type of salt is not particularly limited as long as it is a pharmacologically acceptable salt, and may be an inorganic salt or an organic salt. Examples of inorganic salts include hydrochlorides, sulfates, phosphates, hydrobromides, sodium salts, potassium salts, magnesium salts, calcium salts, magnesium salts, ammonium salts and the like. Examples of organic salts include acetates, lactates, maleates, fumarates, tartrates, methanesulfonates, p-toluenesulfonates, triethanolamine salts, amino acid salts and the like.
 (A)成分は、1種または2種以上を配合することができる。(A)成分の配合量は、化粧料の総量に対して、好ましくは0.05~7質量%であり、より好ましくは0.1~6質量%であり、さらに好ましくは1~6質量%である。 (A) component can be blended one or two or more. The amount of component (A) is preferably 0.05 to 7% by mass, more preferably 0.1 to 6% by mass, and still more preferably 1 to 6% by mass, relative to the total amount of the cosmetic. is.
(B)微細セルロース繊維
 本発明による化粧料は、(B)微細セルロース繊維を含んでなる。本発明において、(B)成分は、植物由来のセルロースからなるナノファイバー(ミクロフィブリル)を意味する。(B)成分は、より好ましくは、ミクロフィブリル同士が実質的に1本ずつにまで分散されたもの(セルロースシングルナノファイバー:CSNFとも呼ばれる)である。セルロースシングルナノファイバーは、水に対する高い増粘作用を有する。
(B) Fine Cellulose Fibers The cosmetic according to the present invention comprises (B) fine cellulose fibers. In the present invention, component (B) means nanofibers (microfibrils) made of plant-derived cellulose. Component (B) is more preferably composed of microfibrils substantially dispersed one by one (also called cellulose single nanofibers: CSNF). Cellulose single nanofibers have a high thickening effect on water.
 (B)成分は好ましくは結晶セルロースを含む。より好ましくは、(B)成分を構成するセルロースが、I型結晶構造を有する。好ましい一形態において、(B)成分は、I型結晶構造を有する天然由来のセルロース固体原料を表面酸化し、微細化した繊維である。天然セルロースの生合成の過程においては、ほぼ例外なくミクロフィブリルと呼ばれるナノファイバーがまず形成され、これらが多束化して高次な固体構造を構成するが、好ましい形態において、微細セルロール繊維は、上記ミクロフィブリル間の強い凝集力の原動となっている表面間の水素結合を弱めるために、その水酸基の一部が酸化され、アルデヒド基およびカルボキシル基に変換されている。
 微細セルロース繊維を構成するセルロースがI型結晶構造を有することは、例えば、広角X線回折像測定により得られる回折プロファイルにおいて、2シータ=14~17°付近と、2シータ=22~23°付近の2つの位置に典型的なピークを持つことから同定することができる。
(B) Component preferably contains crystalline cellulose. More preferably, the cellulose constituting component (B) has a type I crystal structure. In a preferred embodiment, the component (B) is fibers obtained by subjecting a naturally-derived solid cellulose raw material having a type I crystal structure to surface oxidation and refining. In the process of biosynthesis of natural cellulose, nanofibers called microfibrils are first formed almost without exception, and these bundles are bundled to form a higher-order solid structure. In order to weaken the intersurface hydrogen bonds that drive the strong cohesive forces between microfibrils, some of the hydroxyl groups have been oxidized and converted to aldehyde and carboxyl groups.
The cellulose constituting the fine cellulose fibers has a type I crystal structure, for example, in the diffraction profile obtained by wide-angle X-ray diffraction image measurement, 2 theta = 14 to 17 ° and 2 theta = 22 to 23 °. can be identified by having typical peaks at two positions of .
 好ましい形態において、(B)成分は、セルロース分子中のグルコースユニットのC6位の水酸基が選択的に酸化されてアルデヒド基およびカルボキシル基に変性されている。カルボキシル基量は、好ましくは0.6~2.2mmol/gであり、保形性能、分散安定性の点から、より好ましくは0.6~2.0mmol/gである。アルデヒド基量は、好ましくは0.03~0.3mmol/gであり、より好ましくは0.10~0.25mmol/gである。微細セルロース繊維に含まれるカルボキシル基量およびアルデヒド基量の測定は、微細セルロース繊維を分散させた水の電位差滴定により行うことができる。
 微細セルロース繊維におけるカルボキシル基量およびアルデヒド基量の調整は、セルロース繊維の酸化工程で用いる共酸化剤の添加量や反応時間を制御することにより行うことができる。また、微細セルロース繊維にアルデヒド基あるいはカルボキシル基が導入されていることは、全反射式赤外分光スペクトル(ATR)解析により確認できる。
In a preferred embodiment, component (B) is modified by selectively oxidizing the hydroxyl group at the C6 position of the glucose unit in the cellulose molecule into an aldehyde group and a carboxyl group. The amount of carboxyl groups is preferably 0.6 to 2.2 mmol/g, more preferably 0.6 to 2.0 mmol/g from the viewpoint of shape retention performance and dispersion stability. The amount of aldehyde groups is preferably 0.03-0.3 mmol/g, more preferably 0.10-0.25 mmol/g. The amount of carboxyl groups and the amount of aldehyde groups contained in the fine cellulose fibers can be measured by potentiometric titration of water in which the fine cellulose fibers are dispersed.
The amount of carboxyl groups and the amount of aldehyde groups in the fine cellulose fibers can be adjusted by controlling the amount of co-oxidizing agent added and the reaction time used in the step of oxidizing the cellulose fibers. Further, introduction of an aldehyde group or a carboxyl group into the fine cellulose fibers can be confirmed by total reflection infrared spectroscopy (ATR) analysis.
 (B)成分の最大繊維径は好ましくは1000nm以下であり、より好ましくは最大繊維径が1000nm以下、かつ数平均繊維径が2~100nmであり、分散安定性の点から、最大繊維径が500nm以下、かつ数平均繊維径が3~80nmであることがさらに好ましい。
 微細セルロース繊維の数平均繊維径および最大繊維径は、例えば、次のようにして測定することができる。セルロース繊維に水を加え、セルロースの固形分を1質量%とする。これを、超音波ホモジナイザー、高圧ホモジナイザー、回転速度15,000rpm以上の能力を有するブレンダー等を用いて分散させた後、水を加えて希釈し、親水化処理済みのカーボン膜被覆グリッド上にキャストして、これを透過型電子顕微鏡(TEM)等により観察し、得られた画像からセルロース繊維の数平均繊維径、最大繊維径を測定および算出することができる。
The maximum fiber diameter of component (B) is preferably 1000 nm or less, more preferably 1000 nm or less and a number average fiber diameter of 2 to 100 nm, and from the viewpoint of dispersion stability, the maximum fiber diameter is 500 nm. It is more preferable that the number average fiber diameter is 3 to 80 nm.
The number average fiber diameter and maximum fiber diameter of fine cellulose fibers can be measured, for example, as follows. Water is added to the cellulose fibers to adjust the solid content of cellulose to 1% by mass. After dispersing this by using an ultrasonic homogenizer, a high-pressure homogenizer, a blender capable of rotating at a speed of 15,000 rpm or more, etc., it is diluted by adding water and cast on a carbon film-coated grid that has been hydrophilized. Then, this is observed with a transmission electron microscope (TEM) or the like, and the number average fiber diameter and maximum fiber diameter of the cellulose fibers can be measured and calculated from the obtained image.
 微細セルロース繊維の上記の具体的な測定方法等は、特許第5243371号公報に開示された方法を採用することができる。 The method disclosed in Japanese Patent No. 5243371 can be adopted as the above-described specific method for measuring fine cellulose fibers.
 (B)成分として、例えば、「レオクリスタ」という商品名で第一工業製薬株式会社から市販されている商品を使用することができる。例えば、「レオクリスタC-2SP」(商品名)は、2質量%の微細セルロース繊維、1質量%のフェノキシエタノールを97質量%の水中に含む製品である。 As the component (B), for example, a product commercially available from Daiichi Kogyo Seiyaku Co., Ltd. under the trade name of "Rheocrysta" can be used. For example, "Rheocrysta C-2SP" (trade name) is a product containing 2% by mass of fine cellulose fibers, 1% by mass of phenoxyethanol in 97% by mass of water.
 (B)成分の配合量は、化粧料の総量に対して、好ましくは0.005~1質量%であり、より好ましくは0.005~0.3質量%であり、さらに好ましくは0.015~0.15質量%であり、よりさらに好ましくは0.015~0.08質量%である。 The blending amount of component (B) is preferably 0.005 to 1% by mass, more preferably 0.005 to 0.3% by mass, and still more preferably 0.015, relative to the total amount of the cosmetic. 0.15% by mass, and more preferably 0.015 to 0.08% by mass.
 (B)成分の配合量に対する(A)成分の配合量((A)/(B))は、質量比で、好ましくは1~300であり、より好ましくは50~280である。 The blending amount of component (A) with respect to the blending amount of component (B) ((A)/(B)) is preferably 1-300, more preferably 50-280, in mass ratio.
(C)水
 本発明による化粧料は、(C)水を含んでなる。水としては、化粧品、医薬部外品等に使用される水を使用することができ、例えば、精製水、イオン交換水、水道水等を使用することができる。
 水の配合量は、本発明による化粧料の総量に対して、好ましくは40~95質量%であり、より好ましくは50~90質量%である。
(C) Water The cosmetic according to the present invention comprises (C) water. As water, water used in cosmetics, quasi-drugs, etc. can be used, and for example, purified water, ion-exchanged water, tap water, etc. can be used.
The blending amount of water is preferably 40 to 95% by mass, more preferably 50 to 90% by mass, based on the total amount of the cosmetic composition according to the present invention.
(D)サクシノグリカン
 本発明の化粧料は、(D)サクシノグリカンをさらに含むことができる。サクシノグリカンは、微生物に由来する多糖類の一種であり、ガラクトースおよびグルコースから誘導される糖単位に加え、コハク酸およびピルビン酸並びに随意成分としての酢酸、またはこれらの酸の塩から誘導される単位を含むものである。より具体的にはサクシノグリカンは、グルコース単位:ガラクトース単位:コハク酸単位:ピルビン酸単位を約7:1:1:1で含む、水溶性高分子である。
(D) Succinoglycan The cosmetic of the present invention can further contain (D) succinoglycan. Succinoglycans are a class of microbially derived polysaccharides derived from sugar units derived from galactose and glucose, plus succinic and pyruvic acids and optionally acetic acid, or salts of these acids. It contains units. More specifically, succinoglycans are water-soluble macromolecules containing approximately 7:1:1:1 glucose units: galactose units: succinate units: pyruvate units.
 (D)成分の配合量は、化粧料の総量に対して、好ましくは0.005~1質量%であり、より好ましくは0.01~0.5質量%であり、さらに好ましくは0.01~0.1質量%である。 The blending amount of component (D) is preferably 0.005 to 1% by mass, more preferably 0.01 to 0.5% by mass, and still more preferably 0.01%, based on the total amount of the cosmetic. ~0.1% by mass.
 (D)成分の配合量に対する(A)成分の配合量((A)/(D))は、質量比で、好ましくは1~300であり、より好ましくは50~200である。 The blending amount of component (A) relative to the blending amount of component (D) ((A)/(D)) is preferably 1 to 300, more preferably 50 to 200, in mass ratio.
(E)ポリエチレングリコール
 本発明による化粧料は、(E)ポリエチレングリコール(PEG)をさらに含むことができる。(E)成分の好ましい重量平均分子量は、150~23000であり、より好ましくは150~3000である。(E)成分としては、例えば、PEG-6、PEG-20、PEG-32、PEG-75、PEG-400等が挙げられる。
(E) Polyethylene glycol The cosmetic according to the present invention may further contain (E) polyethylene glycol (PEG). Component (E) preferably has a weight average molecular weight of 150 to 23,000, more preferably 150 to 3,000. Component (E) includes, for example, PEG-6, PEG-20, PEG-32, PEG-75, PEG-400 and the like.
 (E)成分は1種または2種以上を配合することができる。(E)成分の配合量は、化粧料の総量に対して、好ましくは0.1~5質量%であり、より好ましくは0.3~3質量%であり、さらに好ましくは0.7~2質量%である。 (E) component can be blended one or two or more. The blending amount of component (E) is preferably 0.1 to 5% by mass, more preferably 0.3 to 3% by mass, and still more preferably 0.7 to 2%, based on the total amount of the cosmetic. % by mass.
 本発明による化粧料には、上記成分の他、通常化粧品や医薬品に用いられる任意成分を配合することができる。任意成分としては例えば、保湿剤、低級アルコール、増粘剤、界面活性剤、金属イオン封鎖剤、中和剤、pH調整剤、酸化防止剤、防腐剤、薬剤等が挙げられ、本発明の効果を奏する限り、一種または二種以上を配合することができる。 In addition to the above ingredients, the cosmetics according to the present invention can contain optional ingredients that are usually used in cosmetics and pharmaceuticals. Examples of optional ingredients include moisturizers, lower alcohols, thickeners, surfactants, sequestering agents, neutralizers, pH adjusters, antioxidants, preservatives, drugs, and the like, and the effects of the present invention. 1 or 2 or more can be blended as long as the
 保湿剤としては、例えば、プロピレングリコール、ジプロピレングリコール(DPG)、グリセリン、1,3-ブチレングリコール(BG)、エリスリトール、キシリトール、ソルビトール、マルチトール、コンドロイチン硫酸、ヒアルロン酸、ムコイチン硫酸、カロニン酸、アテロコラーゲン、コレステリル-12-ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、dl-ピロリドンカルボン酸塩、短鎖可溶性コラーゲン、イザヨイバラ抽出物、セイヨウノコギリソウ抽出物、メリロート抽出物等が挙げられる。 Examples of moisturizing agents include propylene glycol, dipropylene glycol (DPG), glycerin, 1,3-butylene glycol (BG), erythritol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronin acid, Atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salts, dl-pyrrolidone carboxylate, short-chain soluble collagen, rose rose extract, yarrow extract, melilot extract and the like.
 低級アルコールとしては、例えば、エタノール、1-プロパノール、2-プロパノール、イソブチルアルコール、t-ブチルアルコール等が挙げられる。 Examples of lower alcohols include ethanol, 1-propanol, 2-propanol, isobutyl alcohol, t-butyl alcohol and the like.
 増粘剤としては、例えば、アラビアガム、カラギーナン、カラヤガム、トラガカントガム、キャロブガム、クインスシード(マルメロ)、カゼイン、デキストリン、ゼラチン、ペクチン酸ナトリウム、アラギン酸ナトリウム、PVA、PVM、PVP、ポリアクリル酸ナトリウム、カルボキシビニルポリマー(カルボマー)、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、(アクリロイルジメチルタウリンアンモニウムメタクリル酸べへネス-25)クロスポリマー、(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー、ローカストビーンガム、グアガム、タマリントガム、キサンタンガム、ケイ酸アルミニウムマグネシウム、ベントナイト、ヘクトライト、ケイ酸A1Mg(ビーガム)、ラポナイト、無水ケイ酸等が挙げられる。 Thickeners include, for example, gum arabic, carrageenan, karaya gum, tragacanth gum, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium araginate, PVA, PVM, PVP, sodium polyacrylate, Carboxyvinyl polymer (carbomer), (dimethylacrylamide/acryloyldimethyltaurate Na) crosspolymer, (acryloyldimethyltaurate ammonium/VP) copolymer, (acryloyldimethyltaurate ammonium methacrylate beheneth-25) crosspolymer, (acrylate Na/ Acryloyldimethyltaurate Na) copolymer, locust bean gum, guar gum, tamarind gum, xanthan gum, magnesium aluminum silicate, bentonite, hectorite, A1Mg silicate (Vegum), laponite, silicic anhydride and the like.
 親油性非イオン性界面活性剤としては、例えば、親油性非イオン性界面活性剤としては、例えば、ソルビタンモノオレエート、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ソルビタンセスキオレエート、ペンタ-2-エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル類、モノステアリン酸グリセリン、α,α’-オレイン酸ピログルタミン酸グリセリン、モノステアリン酸グリセリンリンゴ酸エステル等のグリセリンまたはポリグリセリンのエステル類、モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類、硬化ヒマシ油誘導体、グリセリンアルキルエーテル等が挙げられる。 Lipophilic nonionic surfactants include, for example, lipophilic nonionic surfactants such as sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostea sorbitan fatty acid esters such as sorbitan sesquioleate, diglycerol sorbitan penta-2-ethylhexylate, glycerin such as glyceryl monostearate, α,α'-oleic acid pyroglutamic acid glyceryl, glyceryl monostearate malate or Polyglycerin esters, propylene glycol fatty acid esters such as propylene glycol monostearate, hydrogenated castor oil derivatives, glycerin alkyl ethers and the like can be mentioned.
 親水性非イオン性界面活性剤としては、例えば、ポリオキシエチレンソルビタンモノオレエート、ポリオキシエチレンソルビタンモノステアレート等のポリオキシエチレンソルビタン脂肪酸エステル類;ポリオキシエチレンソルビットモノラウレート、ポリオキシエチレンソルビットモノオレエート、ポリオキシエチレンソルビットモノステアレート等のポリオキシエチレンソルビット脂肪酸エステル類;ポリオキシエチレングリセリンモノステアレート、ポリオキシエチレングリセリンモノイソステアレート、ポリオキシエチレングリセリントリイソステアレート、等のポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンモノオレエート、ポリオキシエチレンジステアレート、等のポリオキシエチレン脂肪酸エステル類;ポリオキシエチレンラウリルエーテル、ポリオキシエチレンオレイルエーテル、ポリオキシエチレンステアリルエーテル、ポリオキシエチレン-2-オクチルドデシルエーテル、ポリオキシエチレンコレスタノールエーテル等のポリオキシエチレンアルキルエーテル類;ポリオキシエチレンオクチルフェニルエーテル、ポリオキシエチレンノニルフェニルエーテル、ポリオキシエチレンジノニルフェニルエーテル、等のポリオキシエチレンアルキルフェニルエーテル類;プルロニック等のプルロニック型界面活性剤;ポリオキシエチレンポリオキシプロピレンセチルエーテル、ポリオキシエチレンポリオキシプロピレン-2-デシルテトラデシルエーテル、ポリオキシエチレンポリオキシプロピレンモノブチルエーテル、ポリオキシエチレンポリオキシプロピレン、水添ラノリン、ポリオキシエチレンポリオキシプロピレングリセリンエーテル、PPG-13デシルテトラデセス-24等のポリオキシエチレンポリオキシプロピレンアルキルエーテル類;テトロニック等のテトラポリオキシエチレン・テトラポリオキシプロピレンエチレンジアミン縮合物類;ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレン硬化ヒマシ油モノイソステアレート、ポリオキシエチレン硬化ヒマシ油トリイソステアレート、ポリオキシエチレン硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、ポリオキシエチレン硬化ヒマシ油マレイン酸エステル等のポリオキシエチレンヒマシ油誘導体またはポリオキシエチレン硬化ヒマシ油誘導体;ヤシ油脂肪酸ジエタノールアミド、ラウリン酸モノエタノールアミド、脂肪酸イソプロパノールアミド等のアルカノールアミドのほか、ポリオキシエチレンプロピレングリコール脂肪酸エステル類、ポリオキシエチレンアルキルアミン類、ポリオキシエチレン脂肪酸アミド、ショ糖脂肪酸エステル、ポリオキシエチレンノニルフェニルホルムアルデヒド縮合物、アルキルエトキシジメチルアミンオキシド、トリオレイルリン酸等が挙げられる。 Examples of hydrophilic nonionic surfactants include polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene sorbitan monooleate and polyoxyethylene sorbitan monostearate; polyoxyethylene sorbit monolaurate, polyoxyethylene sorbit Polyoxyethylene sorbitol fatty acid esters such as monooleate and polyoxyethylene sorbitol monostearate; Polyoxyethylene fatty acid esters such as oxyethylene glycerin fatty acid ester, polyoxyethylene monooleate, polyoxyethylene distearate; polyoxyethylene lauryl ether, polyoxyethylene oleyl ether, polyoxyethylene stearyl ether, polyoxyethylene -polyoxyethylene alkyl ethers such as 2-octyldodecyl ether and polyoxyethylene cholestanol ether; polyoxyethylene alkyl ethers such as polyoxyethylene octylphenyl ether, polyoxyethylene nonylphenyl ether and polyoxyethylene dinonylphenyl ether Phenyl ethers; pluronic surfactants such as pluronic; polyoxyethylene polyoxypropylene cetyl ether, polyoxyethylene polyoxypropylene-2-decyltetradecyl ether, polyoxyethylene polyoxypropylene monobutyl ether, polyoxyethylene polyoxy Propylene, hydrogenated lanolin, polyoxyethylene polyoxypropylene glycerin ether, polyoxyethylene polyoxypropylene alkyl ethers such as PPG-13 decyltetradeceth-24; tetrapolyoxyethylene/tetrapolyoxypropylene ethylenediamine such as Tetronic Condensates; polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene hydrogenated castor oil monoisostearate, polyoxyethylene hydrogenated castor oil triisostearate, polyoxyethylene hydrogenated castor oil monopyroglutamic acid monoisostearate Acid diesters, polyoxyethylene hydrogenated castor oil derivatives or polyoxyethylene hydrogenated castor oil derivatives such as polyoxyethylene hydrogenated castor oil maleic acid ester; alkanolamides such as coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide, etc. , polyoxyethylene propylene glycol fatty acid esters, polyoxyethylene alkylamines, polyoxyethylene fatty acid amides, sucrose fatty acid esters, polyoxyethylene nonylphenyl formaldehyde condensates, alkylethoxydimethylamine oxides, trioleyl phosphate, etc. be done.
 アニオン性界面活性剤としては、例えば、ラウリン酸ナトリウム、パルミチン酸ナトリウム等の脂肪酸石鹸、ラウリル硫酸ナトリウム、ラウリル硫酸カリウム、等の高級アルキル硫酸エステル塩;ポリオキシエチレンラウリル硫酸トリエタノールアミン、ポリオキシエチレンラウリル硫酸ナトリウム等のアルキルエーテル硫酸エステル塩;ラウロイルサルコシンナトリウム等のN-アシルサルコシン酸、N-ミリストイル-N-メチルタウリンナトリウム、N-ステアロイル-N-メチルタウリンナトリウム、ヤシ油脂肪酸メチルタウリッドナトリウム、ラウリルメチルタウリッドナトリウム等の高級脂肪酸アミドスルホン酸塩;ポリオキシエチレンオレイルエーテルリン酸ナトリウム、ポリオキシエチレンステアリルエーテルリン酸ナトリウム等のリン酸エステル塩;ジ-2-エチルヘキシルスルホコハク酸ナトリウム、モノラウロイルモノエタノールアミドポリオキシエチレンスルホコハク酸ナトリウム、ラウリルポリプロピレングリコールスルホコハク酸ナトリウム等のスルホコハク酸塩;リニアドデシルベンゼンスルホン酸ナトリウム、リニアドデシルベンゼンスルホン酸トリエタノールアミン等のアルキルベンゼンスルホン酸塩;N-ラウロイルグルタミン酸モノナトリウム、N-ステアロイルグルタミン酸ジナトリウム等のN-アシルグルタミン酸;硬化ヤシ油脂肪酸グリセリン硫酸ナトリウム等の高級脂肪酸エステル硫酸エステル塩のほか、ポリオキシエチレンアルキルエーテルカルボン酸塩、α-オレフィンスルホン酸塩、高級脂肪酸エステルスルホン酸塩、二級アルコール硫酸エステル塩、高級脂肪酸アルキロールアミド硫酸エステル塩、ラウロイルモノエタノールアミドコハク酸ナトリウム、N-パルミトイルアスパラギン酸、ジトリエタノールアミン、ヤシ油脂肪酸コラーゲン加水分解アルカリ塩などが挙げられる。 Examples of anionic surfactants include fatty acid soaps such as sodium laurate and sodium palmitate; higher alkyl sulfate salts such as sodium lauryl sulfate and potassium lauryl sulfate; Alkyl ether sulfate ester salts such as sodium lauryl sulfate; N-acylsarcosic acid such as sodium lauroyl sarcosinate, sodium N-myristoyl-N-methyltaurate, sodium N-stearoyl-N-methyltaurate, sodium cocoate methyl tauride, Higher fatty acid amide sulfonates such as sodium lauryl methyl tauride; Phosphate ester salts such as sodium polyoxyethylene oleyl ether phosphate and sodium polyoxyethylene stearyl ether phosphate; sulfosuccinates such as sodium ethanolamide polyoxyethylene sulfosuccinate and sodium lauryl polypropylene glycol sulfosuccinate; alkylbenzene sulfonates such as sodium linadodecylbenzene sulfonate and triethanolamine linadodecylbenzene sulfonate; monosodium N-lauroyl glutamate, N-acylglutamic acid such as disodium N-stearoylglutamic acid; higher fatty acid esters such as hydrogenated coconut oil fatty acid sodium glycerin sulfate, sulfuric acid ester salts, polyoxyethylene alkyl ether carboxylates, α-olefin sulfonates, higher fatty acid esters sulfonates, secondary alcohol sulfates, higher fatty acid alkylolamide sulfates, sodium lauroyl monoethanolamide succinate, N-palmitoyl aspartic acid, ditriethanolamine, coconut oil fatty acid collagen hydrolyzed alkaline salts, etc. .
 カチオン界面活性剤としては、例えば、塩化ステアリルトリメチルアンモニウム、塩化ラウリルトリメチルアンモニウム等のアルキルトリメチルアンモニウム塩、塩化ジステアリルジメチルアンモニウム等のジアルキルジメチルアンモニウム塩;塩化ポリ(N,N'-ジメチル-3,5,-メチレンピペリジニウム)、塩化セチルピリジニウム等のアルキルピリジニウム塩のほか、アルキル四級アンモニウム塩、アルキルジメチルベンジルアンモニウム塩、アルキルイソキノリニウム塩、ジアルキルモリホニウム塩、ポリオキシエチレンアルキルアミン、アルキルアミン塩、ポリアミン脂肪酸誘導体、アミルアルコ-ル脂肪酸誘導体、塩化ベンザルコニウム、塩化ベンゼトニウム、カチオンポリマー、アクリル酸β-N-N-ジメチル-N-エチルアンモニオエチル塩化ビニルピロリドン共重合体等が挙げられる。 Examples of cationic surfactants include alkyltrimethylammonium salts such as stearyltrimethylammonium chloride and lauryltrimethylammonium chloride; dialkyldimethylammonium salts such as distearyldimethylammonium chloride; ,-methylenepiperidinium), alkylpyridinium salts such as cetylpyridinium chloride, alkylquaternary ammonium salts, alkyldimethylbenzylammonium salts, alkylisoquinolinium salts, dialkylmorphonium salts, polyoxyethylenealkylamines, Alkylamine salts, polyamine fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride, benzethonium chloride, cationic polymers, β-NN-dimethyl-N-ethylammonioethyl chloride vinylpyrrolidone chloride copolymers, etc. be done.
 両性界面活性剤としては、例えば、2-ウンデシル-N,N,N,-(ヒドロキシエチルカルボキシメチル)-2-イミダゾリンナトリウム、2-ココイル-2-イミダゾリニウムヒドロキサイド-1-カルボキシエチロキシ2ナトリウム塩等のイミダゾリン系両性界面活性剤;2-ヘプタデシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン、ラウリルジメチルアミノ酢酸ベタイン、アルキルベタイン、アミドベタイン、スルホベタイン等のベタイン系両性界面活性剤等が挙げられる。 Amphoteric surfactants include, for example, 2-undecyl-N,N,N,-(hydroxyethylcarboxymethyl)-2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy 2 imidazoline-based amphoteric surfactants such as sodium salts; betaine-based amphoteric surfactants such as 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetate betaine, alkylbetaine, amidobetaine, sulfobetaine, etc. agents and the like.
 金属イオン封鎖剤としては、例えば、1-ヒドロキシエタン-1,1-ジフォスホン酸、1-ヒドロキシエタン-1,1-ジフォスホン酸四ナトリウム塩、エデト酸二ナトリウム(EDTA-2Na)、エデト酸三ナトリウム、エデト酸四ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、コハク酸、エデト酸、エチレンジアミンヒドロキシエチル三酢酸3ナトリウム等が挙げられる。 Examples of sequestering agents include 1-hydroxyethane-1,1-diphosphonic acid, tetrasodium 1-hydroxyethane-1,1-diphosphonic acid, disodium edetate (EDTA-2Na), and trisodium edetate. , tetrasodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, succinic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate, and the like.
 中和剤としては、例えば、2-アミノ-2-メチル-1-プロパノール、2-アミノ-2-メチル-1,3-プロパンジオール、水酸化カリウム、水酸化ナトリウム、トリエタノールアミン、炭酸ナトリウム等が挙げられる。 Examples of neutralizing agents include 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, potassium hydroxide, sodium hydroxide, triethanolamine, sodium carbonate, and the like. is mentioned.
 pH調製剤としては、例えば、乳酸-乳酸ナトリウム、クエン酸-クエン酸ナトリウム、コハク酸-コハク酸ナトリウム等の緩衝剤等が挙げられる。
 酸化防止剤としては、例えば、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、ピロ亜硫酸ナトリウム、没食子酸エステル類等が挙げられる。
 防腐剤としては、例えば、メチルパラベン、エチルパラベン、ブチルパラベン等のパラオキシ安息香酸エステル類、安息香酸、サリチル酸、ソルビン酸、パラクロルメタクレゾール、ヘキサクロロフェン、塩化ベンザルコニウム、塩化クロルヘキシジン、トリクロロカルバニリド、感光素、フェノキシエタノール等が挙げられる。
Examples of pH adjusters include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
Examples of antioxidants include dibutylhydroxytoluene, butylhydroxyanisole, sodium pyrosulfite, and gallic acid esters.
Examples of antiseptics include paraoxybenzoic acid esters such as methylparaben, ethylparaben, and butylparaben, benzoic acid, salicylic acid, sorbic acid, parachlorometacresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, and trichlorocarbanilide. , a photosensitive element, phenoxyethanol, and the like.
 薬剤としては、例えば、アスコルビン酸(ビタミンC)、トラネキサム酸、コウジ酸、エラグ酸、アルブチン、アルコキシサリチル酸、グリチルリチン酸、トコフェロール、レチノール、およびこれらの塩または誘導体(例えば、L-アスコルビン酸ナトリウム、L-アスコルビン酸エステルマグネシウム塩、L-アスコルビン酸グルコシド、2-O-エチル-L-アスコルビン酸、3-O-エチル-L-アスコルビン酸、4-メトキシサリチル酸ナトリウム塩、4-メトキシサリチル酸カリウム塩、グリチルリチン酸ジカリウム、グリチルリチン酸ステアリル、酢酸トコフェロール、酢酸レチノール、パルミチン酸レチノール等)、ニコチン酸およびその誘導体(例えば、ニコチン酸アミド)、カフェイン、タンニン、ベラパミルおよびその誘導体、甘草抽出物、グラブリジン、火棘の果実の熱水抽出物、各種生薬、加水分解シルク、加水分解コンキオリン、チャエキス、トルメンチラ根エキス、アシタバ葉/茎エキス、アロエベラ葉エキス、サクラ葉エキス、トウキ根エキス、シイクワシャー果皮エキス、イリス根エキス、トゲキリンサイ/ヒヂリメン/ミツイシコンブ/ウスバアオノリ/ワカメエキス、ガマ穂エキス、ヒキオコシ葉/茎エキス、ツバキ種子エキス、ミツイシコンブ/ワカメエキス、ミシマサイコ根エキス、オランダガラシ葉/茎エキス、カシア樹皮エキス、ローズマリー葉油、ラベンダー油、グルタミン酸、トリメチルグリシン、クロルフェネシン、メントキシプロパンジオール等が挙げられる。 Examples of drugs include ascorbic acid (vitamin C), tranexamic acid, kojic acid, ellagic acid, arbutin, alkoxysalicylic acid, glycyrrhizic acid, tocopherol, retinol, and salts or derivatives thereof (e.g., sodium L-ascorbate, L -ascorbic acid ester magnesium salt, L-ascorbic acid glucoside, 2-O-ethyl-L-ascorbic acid, 3-O-ethyl-L-ascorbic acid, 4-methoxysalicylic acid sodium salt, 4-methoxysalicylic acid potassium salt, glycyrrhizin dipotassium acid, stearyl glycyrrhizinate, tocopherol acetate, retinol acetate, retinol palmitate, etc.), nicotinic acid and its derivatives (e.g. nicotinamide), caffeine, tannins, verapamil and its derivatives, licorice extract, glabridin, fire thorns fruit hot water extract, various crude drugs, hydrolyzed silk, hydrolyzed conchiolin, tea extract, tormentilla root extract, Angelica keiskei leaf/stem extract, aloe vera leaf extract, cherry leaf extract, angelica root extract, shiikuwasha pericarp extract, iris root extract , Soarthorn/Hijirimen/Mitsui kelp/Usuva green laver/Wakame extract, Cattail extract, Toad leaf/stem extract, Camellia seed extract, Honey kelp/Wakame extract, Mishima radish root extract, Dutch mustard leaf/stem extract, Cassia bark extract, Rosemary Leaf oil, lavender oil, glutamic acid, trimethylglycine, chlorphenesin, menthoxypropanediol and the like.
 その他、紫外線吸収剤、粉末成分、香料等も適宜配合することができる。 In addition, UV absorbers, powder ingredients, fragrances, etc. can be added as appropriate.
 本発明による化粧料の剤型は、例えば、溶液系、可溶化系、乳化系、水2-油二層系、水-油-粉末三層系等が挙げられ、特に限定されない。
 本発明による化粧料としては、例えば、スキンケア化粧料(例えば、化粧水、乳液、クリーム、美容液、パック等)、メーキャップ化粧料(例えば、ファンデーション、化粧下地等)、皮膚洗浄料(例えば、洗顔料、メイク落とし等)、日焼け止め化粧料、軟膏等が挙げられる。
The dosage form of the cosmetic according to the present invention is not particularly limited and includes, for example, a solution system, a solubilization system, an emulsification system, a water-2-oil two-layer system, and a water-oil-powder three-layer system.
Cosmetics according to the present invention include, for example, skin care cosmetics (e.g. lotions, milky lotions, creams, serums, packs, etc.), makeup cosmetics (e.g., foundations, makeup bases, etc.), skin cleansers (e.g., facial cleansers). cosmetics, makeup removers, etc.), sunscreen cosmetics, ointments, and the like.
 本発明の化粧料は、常法に従って製造することができる。本発明による化粧料が乳化化粧料である場合に、乳化の方法は特に限定されるものではない。 The cosmetic of the present invention can be produced according to a conventional method. When the cosmetic according to the present invention is an emulsified cosmetic, the method of emulsification is not particularly limited.
 以下の例に基づいて本発明を具体的に説明するが、本発明はこれらの例に限定されるものではない。含有量は特記しない限り、総量に対する質量%で示す。 The present invention will be specifically described based on the following examples, but the present invention is not limited to these examples. Unless otherwise specified, the content is shown in % by mass with respect to the total amount.
[実施例1~13および比較例1、2]
 表1および2に示される配合で、実施例1~13および比較例1、2の化粧料を調製した。
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000006
表中、結晶セルロース(セルロースナノファイバー)*1は、最大繊維径が1000nm以下である微細繊維状セルロース微細状セルロース(「レオクリスタC-2SP」(商品名)、第一工業製薬株式会社製)である。なお、「レオクリスタC-2SP」は、2質量%の微細繊維状セルロース、1質量%のフェノキシエタノール(防腐剤)を97質量%の水中に含む製品であり、本明細書および表に記載している質量%は微細繊維状セルロースのみを指し、商品に含まれる水、防腐剤は含まれない。
[Examples 1 to 13 and Comparative Examples 1 and 2]
Cosmetics of Examples 1 to 13 and Comparative Examples 1 and 2 were prepared with the formulations shown in Tables 1 and 2.
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000006
In the table, crystalline cellulose (cellulose nanofiber) * 1 is fine fibrous cellulose fine cellulose (“Rheocrysta C-2SP” (trade name), manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) having a maximum fiber diameter of 1000 nm or less. be. "Rheocrysta C-2SP" is a product containing 2% by mass of fine fibrous cellulose, 1% by mass of phenoxyethanol (preservative) in 97% by mass of water, and is described in the specification and tables. % by mass indicates only fine fibrous cellulose, and does not include water and preservatives contained in the product.
 上記で調製した化粧料を、専門パネル10名が肌に塗布して、塗布中の「みずみずしさ」、塗布後の「べたつきのなさ」、塗布後の「しっとりさ」、および塗布中の「フィット感」について評価した。各専門パネルの評価をもとに、以下の基準に従って評価した。得られた結果は表1および2のとおりである。 The cosmetics prepared above were applied to the skin by 10 specialist panels, and the "freshness" during application, the "non-stickiness" after application, the "moisture" after application, and the "fitness" during application were evaluated. "feeling" was evaluated. Based on the evaluation of each specialized panel, evaluation was made according to the following criteria. The results obtained are shown in Tables 1 and 2.
「みずみずしさ」
 AA:パネル10名全員がみずみずしい感触があると回答した。
 A:パネル10名中7名以上9名以下がみずみずしい感触があると回答した。
 B:パネル10名中4名以上6名以下がみずみずしい感触があると回答した。
 C:パネル10名中1名以上3名以下がみずみずしい感触があると回答した。
 D:パネル10中全員がみずみずしい感触に欠けると回答した。
"Freshness"
AA: All 10 panelists answered that they had a fresh touch.
A: 7 to 9 out of 10 panelists answered that they had a fresh feeling.
B: 4 or more and 6 or less out of 10 panelists answered that they had a fresh feeling.
C: 1 or more and 3 or less out of 10 panelists answered that they had a fresh feeling.
D: All of panel 10 answered that it lacked a fresh feel.
「べたつきのなさ」
 AA:パネル10名全員がべたつきがないと回答した。
 A:パネル10名中7名以上9名以下がべたつきがないと回答した。
 B:パネル10名中4名以上6名以下がべたつきがないと回答した。
 C:パネル10名中1名以上3名以下がべたつきがないと回答した。
 D:パネル10中全員がべたつきがあると回答した。
"No stickiness"
AA: All 10 panelists answered that there was no stickiness.
A: 7 to 9 out of 10 panelists answered that there was no stickiness.
B: 4 to 6 out of 10 panelists answered that there was no stickiness.
C: From 1 to 3 panelists out of 10 panelists answered that there was no stickiness.
D: All panel 10 members answered that there was stickiness.
「しっとりさ」
 AA:パネル10名全員がしっとりさがあると回答した。
 A:パネル10名中7名以上9名以下がしっとりさがあると回答した。
 B:パネル10名中4名以上6名以下がしっとりさがあると回答した。
 C:パネル10名中1名以上3名以下がしっとりさがあると回答した。
 D:パネル10中全員がしっとりさに欠けると回答した。
"Moistness"
AA: All 10 panelists answered that there was moistness.
A: 7 or more and 9 or less out of 10 panelists answered that it was moist.
B: 4 or more and 6 or less out of 10 panelists answered that there was moistness.
C: 1 or more and 3 or less of the 10 panelists answered that the skin was moist.
D: All of panel 10 answered that it lacked moistness.
「フィット感」
 AA:パネル10名全員がフィット感があると回答した。
 A:パネル10名中7名以上9名以下がフィット感があると回答した。
 B:パネル10名中4名以上6名以下がフィット感があると回答した。
 C:パネル10名中1名以上3名以下がフィット感があると回答した。
 D:パネル10中全員がフィット感に欠けると回答した。
"Feeling of fit"
AA: All 10 panelists answered that they had a good fit.
A: 7 or more and 9 or less out of 10 panelists answered that they felt a good fit.
B: 4 or more and 6 or less out of 10 panelists answered that they felt fit.
C: 1 or more and 3 or less of the 10 panelists answered that they had a good fit.
D: All of panel 10 answered that the feeling of fit was lacking.

Claims (11)

  1. (A)式(1)で表される環状カルボキサミド誘導体またはその塩
    Figure JPOXMLDOC01-appb-C000001
    (式中、
     Rは、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、
     Xは、-CH-または-N(R)-であり、ここで、Rは、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、かつ
     nは、1~3の整数である)、
    (B)微細セルロース繊維、および
    (C)水
    を含んでなる化粧料。
    (A) a cyclic carboxamide derivative represented by formula (1) or a salt thereof
    Figure JPOXMLDOC01-appb-C000001
    (In the formula,
    R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom,
    X is —CH 2 — or —N(R 2 )—, wherein R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, and n is an integer from 1 to 3),
    A cosmetic comprising (B) fine cellulose fibers and (C) water.
  2.  (A)成分の式(1)において、
     Rが、炭素数1~3のヒドロキシアルキル基であり、
     Xが、-CH-または-NH-であり、かつ
     nが、1である、請求項1に記載の化粧料。
    (A) In the formula (1) of the component,
    R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms,
    2. The cosmetic according to claim 1, wherein X is -CH 2 - or -NH-, and n is 1.
  3.  (A)成分が、1-(2-ヒドロキシエチル)-2-イミダゾリジノンである、請求項1または2に記載の化粧料。 The cosmetic according to claim 1 or 2, wherein the component (A) is 1-(2-hydroxyethyl)-2-imidazolidinone.
  4.  (A)成分の配合量が、化粧料の総量に対して、0.05~7質量%である、請求項1または2に記載の化粧料。 The cosmetic according to claim 1 or 2, wherein the blending amount of component (A) is 0.05 to 7% by mass with respect to the total amount of the cosmetic.
  5.  (B)成分の最大繊維径が1000nm以下である、請求項1または2に記載の化粧料。 The cosmetic according to claim 1 or 2, wherein the component (B) has a maximum fiber diameter of 1000 nm or less.
  6.  (B)成分の配合量が、化粧料の総量に対して、0.005~1質量%である、請求項1または2に記載の化粧料。 The cosmetic according to claim 1 or 2, wherein the blending amount of component (B) is 0.005 to 1% by mass with respect to the total amount of the cosmetic.
  7.  (B)成分の配合量に対する(A)成分の配合量((A)/(B))が、質量比で、1~300である、請求項1または2に記載の化粧料。 The cosmetic according to claim 1 or 2, wherein the blending amount of component (A) relative to the blending amount of component (B) ((A)/(B)) is 1 to 300 by mass.
  8.  (D)サクシノグリカンをさらに含んでなる、請求項1または2に記載の化粧料。 (D) The cosmetic according to claim 1 or 2, further comprising succinoglycan.
  9.  (D)成分の配合量が、化粧料の総量に対して、0.005~1質量%である、請求項8に記載の化粧料。 The cosmetic according to claim 8, wherein the amount of component (D) is 0.005 to 1% by mass relative to the total amount of the cosmetic.
  10.  (E)ポリエチレングリコールをさらに含んでなる、請求項1または2に記載の化粧料。 (E) The cosmetic according to claim 1 or 2, further comprising polyethylene glycol.
  11.  (E)成分の配合量が、化粧料の総量に対して、0.1~5質量%である、請求項10に記載の化粧料。 The cosmetic according to claim 10, wherein the amount of component (E) is 0.1 to 5% by mass with respect to the total amount of the cosmetic.
PCT/JP2022/043475 2021-12-09 2022-11-25 Cosmetic WO2023106123A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-200010 2021-12-09
JP2021200010 2021-12-09

Publications (1)

Publication Number Publication Date
WO2023106123A1 true WO2023106123A1 (en) 2023-06-15

Family

ID=86730194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/043475 WO2023106123A1 (en) 2021-12-09 2022-11-25 Cosmetic

Country Status (1)

Country Link
WO (1) WO2023106123A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159630A (en) * 1998-09-21 2000-06-13 Shiseido Co Ltd Composition for external use
JP2002020274A (en) * 2000-06-12 2002-01-23 San-A Seiyaku Kk Non-steroidal anti-inflammatory analgesic transdermal patch agent for outer application and transdermal patch for outer application
JP2009286757A (en) * 2008-05-30 2009-12-10 Shiseido Co Ltd O/w-type skin care preparation
WO2011040496A1 (en) * 2009-09-30 2011-04-07 株式会社資生堂 Heparanase activity inhibitor
JP2012126788A (en) * 2010-12-14 2012-07-05 Dai Ichi Kogyo Seiyaku Co Ltd Viscous aqueous composition
JP2016069589A (en) * 2014-10-01 2016-05-09 第一工業製薬株式会社 Method for producing aqueous dispersion of cellulose nanofibers
JP2019014709A (en) * 2017-07-07 2019-01-31 ポーラ化成工業株式会社 Skin care composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159630A (en) * 1998-09-21 2000-06-13 Shiseido Co Ltd Composition for external use
JP2002020274A (en) * 2000-06-12 2002-01-23 San-A Seiyaku Kk Non-steroidal anti-inflammatory analgesic transdermal patch agent for outer application and transdermal patch for outer application
JP2009286757A (en) * 2008-05-30 2009-12-10 Shiseido Co Ltd O/w-type skin care preparation
WO2011040496A1 (en) * 2009-09-30 2011-04-07 株式会社資生堂 Heparanase activity inhibitor
JP2012126788A (en) * 2010-12-14 2012-07-05 Dai Ichi Kogyo Seiyaku Co Ltd Viscous aqueous composition
JP2016069589A (en) * 2014-10-01 2016-05-09 第一工業製薬株式会社 Method for producing aqueous dispersion of cellulose nanofibers
JP2019014709A (en) * 2017-07-07 2019-01-31 ポーラ化成工業株式会社 Skin care composition

Similar Documents

Publication Publication Date Title
EP1658088B1 (en) Prebiotically active composition comprising extracts of pinus sylvestris and ribes nigrum for use in preventing growth of propionibacterium acnes
JP5432470B2 (en) Ceramide solution and external preparation for skin
JP5433128B2 (en) Topical skin preparation
JP2010229068A (en) Skin care preparation for external application
WO2004098557A1 (en) Lipid composition and skin care formulation containing the same
US10524994B2 (en) Conditioning agent and conditioning composition
JP2013107862A (en) Skin cosmetic gel
JP4912032B2 (en) Emulsifier type skin external preparation
JP4927442B2 (en) Skin external preparation in the form of water-in-oil emulsifier
WO2023106123A1 (en) Cosmetic
JP2004137196A (en) Emulsifying agent and cosmetic
JP2019014714A (en) Anti-inflammatory composition
JP2003073251A (en) Skin care preparation
JP2006342122A (en) External preparation for skin
JP2004097999A (en) Emulsifier and cosmetic
RU2761622C2 (en) Composition containing compound of benzoic acid amide and solubilizing agent cyclodextrin
JP5550265B2 (en) Hair cleaner composition
JP6598802B2 (en) Oil-free emollients in sunscreen compositions
JP4365281B2 (en) DFA-containing external preparation for skin, cosmetics, ophthalmic solution
FR2989274A1 (en) Skin cosmetic and/or dermatological composition used to limit the adhesion of pathogenic bacteria e.g. Staphylococcus aureus to skin and to limit troublesome phenomena e.g. acne, comprises rhamnose rich polysaccharide
JP5918528B2 (en) Skin preparation
JP2019069919A (en) Gelatinous composition
JP2002241211A (en) Cosmetic
WO2023047979A1 (en) Oil-in-water emulsified cosmetic material
JP2000319117A (en) Moisture retaining composition containing cellulose fine particle

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22904054

Country of ref document: EP

Kind code of ref document: A1